04:17 PM EDT, 10/30/2025 (MT Newswires) -- Gilead Sciences ( GILD ) reported Q3 non-GAAP earnings late Thursday of $2.47 per diluted share, up from $2.02 a year earlier.

Analysts polled by FactSet expected $2.13.

Revenue for the quarter ended Sept. 30 was $7.77 billion, up from $7.55 billion a year earlier.

Analysts surveyed by FactSet expected $7.45 billion.

The company adjusted its full-year 2025 non-GAAP EPS guidance to a range of $8.05 to $8.25 from $7.95 to $8.25 previously. Analysts surveyed by FactSet expect $8.04.

The company now expects 2025 product sales of $28.40 billion to $28.70 billion, versus prior view of $28.30 billion to $28.70 billion.

The company maintained its quarterly dividend at $0.79 per share, payable Dec. 30 to holders of record Dec. 15.

The company's shares fell 4.2% in after-hours activity.

Price: 113.50, Change: -4.94, Percent Change: -4.17